Intech Investment Management LLC Cuts Position in Acadia Healthcare Company, Inc. $ACHC

Key Points

• Intech Investment Management LLC reduced its stake in Acadia Healthcare by 24.8%, owning 81,275 shares worth approximately $2.46 million after selling 26,875 shares in the first quarter.
• Multiple hedge funds have adjusted their positions in Acadia Healthcare, with UMB Bank increasing its holdings by 149.5% and Caitong International Asset Management up by a staggering 11,218.2%.
• Acadia Healthcare reported earnings of $0.83 per share, surpassing analyst estimates, and has set its FY 2025 guidance at 2.450-2.65 EPS, with projected earnings per share for the current year at 3.38.

Intech Investment Management LLC decreased its position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) by 24.8% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 81,275 shares of the company's stock after selling 26,875 shares during the quarter. Intech Investment Management LLC owned about 0.09% of Acadia Healthcare worth $2,464,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. Caitong International Asset Management Co. Ltd grew its position in Acadia Healthcare by 11,218.2% during the first quarter. Caitong International Asset Management Co. Ltd now owns 1,245 shares of the company's stock worth $38,000 after buying an additional 1,234 shares in the last quarter. UMB Bank n.a. grew its position in Acadia Healthcare by 149.5% during the first quarter. UMB Bank n.a. now owns 1,260 shares of the company's stock worth $38,000 after buying an additional 755 shares in the last quarter. State of Wyoming acquired a new stake in Acadia Healthcare during the fourth quarter worth approximately $56,000. Covestor Ltd grew its position in Acadia Healthcare by 56.0% during the first quarter. Covestor Ltd now owns 2,262 shares of the company's stock worth $69,000 after buying an additional 812 shares in the last quarter. Finally, Twin Tree Management LP grew its position in Acadia Healthcare by 185.8% during the first quarter. Twin Tree Management LP now owns 5,691 shares of the company's stock worth $173,000 after buying an additional 3,700 shares in the last quarter.

Acadia Healthcare Trading Up 0.1%

Shares of ACHC stock traded up $0.02 during mid-day trading on Friday, hitting $22.09. The company's stock had a trading volume of 1,359,827 shares, compared to its average volume of 2,233,048. The company's fifty day simple moving average is $21.90 and its 200-day simple moving average is $23.92. Acadia Healthcare Company, Inc. has a 52 week low of $17.13 and a 52 week high of $77.62. The company has a debt-to-equity ratio of 0.73, a quick ratio of 1.32 and a current ratio of 1.32. The company has a market cap of $2.04 billion, a PE ratio of 14.62, a P/E/G ratio of 4.31 and a beta of 0.89.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last issued its earnings results on Tuesday, August 5th. The company reported $0.83 EPS for the quarter, beating the consensus estimate of $0.71 by $0.12. The company had revenue of $869.23 million during the quarter, compared to the consensus estimate of $839.59 million. Acadia Healthcare had a return on equity of 8.34% and a net margin of 4.31%.The firm's revenue for the quarter was up 9.2% compared to the same quarter last year. During the same period last year, the business posted $0.91 EPS. Acadia Healthcare has set its FY 2025 guidance at 2.450-2.65 EPS. As a group, equities research analysts expect that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of equities research analysts have weighed in on ACHC shares. UBS Group reduced their target price on Acadia Healthcare from $45.00 to $31.00 and set a "buy" rating on the stock in a report on Thursday, August 7th. Guggenheim reduced their target price on Acadia Healthcare from $36.00 to $29.00 and set a "buy" rating on the stock in a report on Thursday, August 7th. Bank of America downgraded Acadia Healthcare from a "buy" rating to a "neutral" rating and reduced their target price for the company from $27.00 to $25.00 in a report on Wednesday, September 10th. Wall Street Zen raised Acadia Healthcare from a "sell" rating to a "hold" rating in a report on Sunday, August 3rd. Finally, Barclays dropped their price target on Acadia Healthcare from $28.00 to $20.00 and set an "equal weight" rating for the company in a research note on Thursday, August 7th. Eight investment analysts have rated the stock with a Buy rating and five have given a Hold rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $39.00.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.